NAUT · NASDAQ · Biotechnology

Nautilus Biotechnology (NAUT)

Builds the Voyager platform for intact-protein and proteoform analysis.

$0.9212
Pre-market−0.04 (−4.22%)
At close$0.9618(+3.81%)

Something off on this page? Send us feedback.

Next report
Oct 27, 2026
in 54 days
EPS estimate
−$0.14
Revenue estimate
$200.0K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported−$0.14−$0.13−$0.12−$0.11−$0.11−$0.12−$0.11Pending
Estimate−$0.16−$0.14−$0.16−$0.15−$0.14−$0.15−$0.14−$0.14
Surprise+12.5%+7.1%+22.6%+26.7%+21.4%+17.2%+18.5%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$9.6M$190.0KPending
Estimate$1.3M$250.0K$100.0K$200.0K
Surprise+90.0%

History

DateEstimateReportedSurprise
Oct 2026−$0.14
Jul 2026−$0.14−$0.11+18.5%
Apr 2026−$0.15−$0.12+17.2%
Feb 2026−$0.14−$0.11+21.4%
Oct 2025−$0.15−$0.11+26.7%

The latest year is open to everyone — the 27 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Feb 2025
Oct 2024
Jul 2024
Apr 2024
Feb 2024
Oct 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
Jun 2021
Mar 2021
Nov 2020
Sep 2020
Jun 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Oct 27, 2026−$0.14$200.0K
Jul 28, 2026−$0.14−$0.11+18.5%$100.0K$190.0K+90.0%−13.3%
Apr 28, 2026−$0.15−$0.12+17.2%$250.0K−3.5%
Feb 26, 2026−$0.14−$0.11+21.4%$1.3M0.0%
Oct 27, 2025−$0.15−$0.11+26.7%+5.9%

The latest year is open to everyone — the 27 quarters behind it read with an account.

Sign in
Jul 31, 2025
Apr 29, 2025
Feb 26, 2025
Oct 29, 2024
Jul 30, 2024
Apr 30, 2024
Feb 28, 2024
Oct 31, 2023
Aug 2, 2023
May 2, 2023
Feb 23, 2023
Nov 1, 2022
Aug 2, 2022
May 3, 2022
Feb 24, 2022
Nov 2, 2021
Aug 10, 2021
Jun 10, 2021
Mar 30, 2021
Nov 13, 2020
Sep 18, 2020
Jun 8, 2020
Mar 6, 2020
Nov 13, 2019
Aug 12, 2019
May 13, 2019
Mar 25, 2019